SCHEMBL17599460

SCHEMBL17599460

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(-c3ccc(C(=O)O)s3)cc3ccccc23)c1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 3/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ CRHBP P24387 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ ACLY P53396 1/20 0.42
▸ KEAP1 Q14145 3/20 0.41
▸ NFE2L2 Q16236 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ FTO Q9C0B1 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ HTT P42858 1/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599472 0.87 ALDH1A1 (0.41) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599467 0.81 KMT2A (0.55) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17613790 0.80 HPGD (0.40) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599510 0.79 KMT2A (0.53) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599435 0.78 ALDH1A1 (0.57) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599466 0.78 KMT2A (0.51) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599429 0.78 KMT2A (0.51) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599423 0.77 ALDH1A1 (0.56) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599483 0.77 MEN1 (0.56) HPGDMEN1KMT2AALDH1A1KDM4E
SCHEMBL17599431 0.77 KMT2A (0.50) HPGDMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998295-A1 Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback